脂质辅助聚合物纳米粒子的优化,用于siRNA输送和癌症免疫治疗
Song Lin1, Houjin Jing1, Xiaojiao Du2
1School of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International Campus, Guangzhou, Guangdong 511442, P. R. China. yangxz@scut.edu.cn.
Biomaterials science
|March 12, 2024
概括
研究人员开发了一种先进的纳米粒子系统,用于将小干扰RNA (siRNA) 传递到肝脏之外. 这种新的siRNA传递系统有效地准CD47,增强免疫反应以抑制黑色素瘤瘤的生长.
科学领域:
- 生物技术和纳米医学
- 癌症免疫疗法癌症免疫疗法
- 抗RNA干扰治疗药物 抗RNA干扰治疗
背景情况:
- 已批准了五种基于小干扰RNA (siRNA) 的药物,但它们的使用主要局限于肝脏疾病,因为交付挑战.
- 有效地将siRNA传递给非肝脏点对于扩大RNA干扰 (RNAi) 治疗应用至关重要.
- CD47是一种关键的免疫检查点蛋白质,促进瘤免疫逃避.
研究的目的:
- 为非肝脏应用开发和优化一种新的siRNA传递系统.
- 创造一种能够有效地使基因沉默和诱导免疫反应的纳米粒子配方.
- 评估通过优化系统传递的CD47向siRNA在抑制黑色素瘤方面的有效性.
主要方法:
- 使用mPEG-b-PLGA,一种阴离子脂质和一种可离子化的脂质制造一个siRNA输送系统.
- 通过精确调整组件质量比,优化纳米粒子配方.
- 在优化的纳米颗粒中封装针对CD47的siRNA.
主要成果:
- 优化的纳米粒子系统展示了高效的基因沉默能力.
- 封装CD47siRNA的纳米粒子配方成功诱导了强大的免疫反应.
- 该治疗有效地通过阻断CD47免疫检查点来抑制黑色素瘤瘤的进展.
结论:
- 一个新的,临床适应性的siRNA传递系统被成功开发和优化.
- 通过该系统传递的CD47向siRNA显示了黑色素瘤免疫治疗的巨大潜力.
- 这种平台技术可以使siRNA疗法在肝脏之外得到更广泛的应用.
更多相关视频
08:31Porous Silicon Microparticles for Delivery of siRNA Therapeutics
Published on: January 15, 2015
10.9K
15:55Long-term Silencing of Intersectin-1s in Mouse Lungs by Repeated Delivery of a Specific siRNA via Cationic Liposomes. Evaluation of Knockdown Effects by Electron Microscopy
Published on: June 21, 2013
10.7K
相关概念视频
siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
